Olesoxime Completed Phase 1 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

Indications	Status	Purpose	Phase
DBCOND0036413 (Relapsing Remitting Multiple Sclerosis (RRMS))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01808885	Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.	Olesoxime (DB05185)